tiprankstipranks
Nordicus Partners (NORD)
OTHER OTC:NORD
US Market

Nordicus Partners (NORD) Stock Price & Analysis

7 Followers

NORD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.40 - $1.50
Previous Close$0.69
Volume1.00
Average Volume (3M)1.13K
Market Cap
$7.61M
Enterprise Value$7.57M
Total Cash (Recent Filing)$38.79K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.5
Beta-0.45
Feb 14, 2018
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.47
Shares Outstanding11,031,248
10 Day Avg. Volume17
30 Day Avg. Volume1,126
Standard Deviation0.34
R-Squared0.01
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)3.88
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-33.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-54.45
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

83.17%0.00%0.00%16.83%
83.17% Insiders
0.00% Other Institutional Investors
16.83% Public Companies and
Individual Investors

NORD FAQ

What was Nordicus Partners’s price range in the past 12 months?
Nordicus Partners lowest stock price was $0.40 and its highest was $1.50 in the past 12 months.
    What is Nordicus Partners’s market cap?
    Currently, no data Available
    When is Nordicus Partners’s upcoming earnings report date?
    Nordicus Partners’s upcoming earnings report date is Feb 14, 2018 which is 2255 days ago.
      How were Nordicus Partners’s earnings last quarter?
      Currently, no data Available
      Is Nordicus Partners overvalued?
      According to Wall Street analysts Nordicus Partners’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Nordicus Partners pay dividends?
        Nordicus Partners pays a Notavailable dividend of $0.25 which represents an annual dividend yield of N/A. See more information on Nordicus Partners dividends here
          What is Nordicus Partners’s EPS estimate?
          Nordicus Partners’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Nordicus Partners have?
          Nordicus Partners has 11,031,248 shares outstanding.
            What happened to Nordicus Partners’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Nordicus Partners?
            Currently, no hedge funds are holding shares in NORD
            ---

            Nordicus Partners Stock Smart Score

            N/A
            Not Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Positive
            20 days / 200 days
            Momentum
            -16.36%
            12-Months-Change

            Fundamentals

            Return on Equity
            -325.72%
            Trailing 12-Months
            Asset Growth
            9999.00%
            Trailing 12-Months

            Company Description

            Nordicus Partners

            AdvanSource Biomaterials Corp. engages in the development of polymer materials, which provides characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Wilmington, MA.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            GSE Systems
            ADM Tronics Unlimited
            Sow Good
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis